iShares S&P 100 Index (OEF) Shares Sold by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. trimmed its holdings in shares of iShares S&P 100 Index (NYSEARCA:OEF) by 10.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 70,644 shares of the company’s stock after selling 8,422 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in iShares S&P 100 Index were worth $8,381,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in OEF. Goldman Sachs Group Inc. raised its holdings in shares of iShares S&P 100 Index by 375.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 3,625,831 shares of the company’s stock valued at $430,168,000 after acquiring an additional 2,862,431 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of iShares S&P 100 Index by 17.8% in the fourth quarter. Jones Financial Companies Lllp now owns 5,938,969 shares of the company’s stock valued at $704,599,000 after acquiring an additional 899,015 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of iShares S&P 100 Index by 106.4% in the fourth quarter. Jane Street Group LLC now owns 5,028 shares of the company’s stock valued at $597,000 after acquiring an additional 83,328 shares in the last quarter. Cliftonlarsonallen Wealth Advisors LLC raised its holdings in shares of iShares S&P 100 Index by 157.9% in the fourth quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 90,590 shares of the company’s stock valued at $10,748,000 after acquiring an additional 55,465 shares in the last quarter. Finally, Citadel Advisors LLC bought a new stake in shares of iShares S&P 100 Index in the fourth quarter valued at about $5,771,000.

How to Become a New Pot Stock Millionaire

iShares S&P 100 Index (NYSEARCA:OEF) opened at $113.47 on Monday. iShares S&P 100 Index has a 52 week low of $103.02 and a 52 week high of $127.67. The stock has a market capitalization of $5,340.00 and a PE ratio of 11.89.

COPYRIGHT VIOLATION NOTICE: This report was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3301282/ishares-sp-100-index-oef-shares-sold-by-cambridge-investment-research-advisors-inc.html.

About iShares S&P 100 Index

iShares S&P 100 ETF, formerly iShares S&P 100 Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P 100 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market and consists of blue chip stocks from diverse industries in the S&P 500 Index.

Want to see what other hedge funds are holding OEF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares S&P 100 Index (NYSEARCA:OEF).

Institutional Ownership by Quarter for iShares S&P 100 Index (NYSEARCA:OEF)

Receive News & Ratings for iShares S&P 100 Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares S&P 100 Index and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Liberum Capital Reiterates Hold Rating for Sports Direct
Liberum Capital Reiterates Hold Rating for Sports Direct
RWS  Rating Reiterated by Shore Capital
RWS Rating Reiterated by Shore Capital
WPP’s  Hold Rating Reiterated at Deutsche Bank
WPP’s Hold Rating Reiterated at Deutsche Bank
Berenberg Bank Raises Ten Entertainment Group  Price Target to GBX 310
Berenberg Bank Raises Ten Entertainment Group Price Target to GBX 310
Evonik Industries  Given a €27.00 Price Target by UBS Analysts
Evonik Industries Given a €27.00 Price Target by UBS Analysts
eMagin  Sees Large Decline in Short Interest
eMagin Sees Large Decline in Short Interest


© 2006-2018 Ticker Report. Google+.